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Introduction:
The benefits of cardiac resynchronization therapy 
(CRT) in the quality of life (QOL) have been largely 
demonstrated in selected patients (P) with severe 
congestive heart failure (CHF). However, the 
differences between responders and non-responders, 
with regard to the effect of CRT in the various 
dimensions of QOL is still a matter of discussion.
Objective:
To evaluate the impact of CRT on the QOL of P with 
CHF refractory to optimal pharmacological therapy, 
within 6 months after CRT.
Population and Methods: 
43P, submitted to successful implantation of CRT, were 
evaluated at the hospital just before CRT implantation 
and in the outpatient clinic within 6 months after CRT. 
QOL was analyzed based on the Kansas City 
Cardiomyopathy Questionnaire (KCCQ). 
Conclusion:
In a population with severe CHF undergoing CRT, the P 
with positive clinical response and reverse remodeling, 
obtained a favorable impact in all dimensions of QOL, 
while the group without response to CRT showed no 
improvement. These data reinforces the importance of 
QOL as a multidimensional tool for assessment of benefits 
in clinical practice.
P were classified as:
super-responders (n=15, left ventricle ejection fraction 
- LVEF - ≥45% post-CRT, 65±8 years, 47% male, pre-
CRT with LVEF of 30±5% and 100% in NYHA class III);
responders (n=19, sustained improvement in 
functional class and LVEF increase by 15%, 63±11 
years, 84% male, pre-CRT with LVEF of 23±6% and 
100% in NYHA class III); 
non-responders (n=9, no clinical or LVEF 
improvement, 63±6 years, 78% male, pre-CRT with 
LVEF 24±7%, 22.2% in class II, 66.7% in class III and 
11.1% in NYHA class IV). 
Results:
In the group of super-responders, CRT was associated 
with an improvement in QOL for the various fields and 
sums assessed (ρ<0.05): 
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In non-responders, CRT was not associated with 
improvement of QOL:
In responders, CRT was associated with an improvement 
of QOL in the various fields and sums, except in the 
knowledge for the clinical condition dimension (ρ<0.05):
